• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

肿瘤内DNA含量变异性。一项关于非小细胞肺癌的研究。

Intratumoral DNA content variability. A study of non-small cell lung cancer.

作者信息

Sara A, el-Naggar A K

机构信息

Department of Pathology, University of Texas M.D. Anderson Cancer Center, Houston 77030.

出版信息

Am J Clin Pathol. 1991 Sep;96(3):311-7. doi: 10.1093/ajcp/96.3.311.

DOI:10.1093/ajcp/96.3.311
PMID:1652200
Abstract

Twenty-eight resected primary non-small cell lung carcinomas were studied for intratumoral DNA variability by flow cytometry (FCM). Three separate tissue specimens from each resected tumor were divided equally for FCM analysis and histologic evaluation. FCM analysis also was performed on fine-needle aspirates (FNAs) from the center of the resected tumor. Histologically, there were 8 squamous carcinomas, 19 adenocarcinomas, and 1 large cell carcinoma. Twenty-three tumors (82%) were aneuploid, and 5 (18%) were diploid. The DNA index in aneuploid neoplasms ranged from 0.91 to 3.30 (mean, 1.64). All 5 diploid and 19 (83%) of the (23) aneuploid neoplasms manifested intratumoral DNA stability. Four (17%) of the aneuploid tumors showed regional DNA heterogeneity expressed as additional stemlines in at least one sample. The FNA yield was sufficient in 21 cases and inadequate for complete analysis in 7 cases. In general, good correlation between FNA and tissue analysis was obtained. However, in three of the aneuploid neoplasms, FNA materials did not reveal an additional nondominant stemline, as noted in the tissue specimens. The authors attribute this finding to a dilutional factor in the aspiration material. The authors conclude that most non-small cell lung carcinomas express DNA stability; FNA provides adequate cellular material for FCM in most cases.

摘要

对28例手术切除的原发性非小细胞肺癌进行了流式细胞术(FCM)检测,以研究肿瘤内DNA的变异性。将每个切除肿瘤的三个独立组织标本平均分为两份,分别用于FCM分析和组织学评估。还对切除肿瘤中心的细针穿刺抽吸物(FNA)进行了FCM分析。组织学上,有8例鳞状细胞癌、19例腺癌和1例大细胞癌。23例肿瘤(82%)为非整倍体,5例(18%)为二倍体。非整倍体肿瘤的DNA指数范围为0.91至3.30(平均为1.64)。所有5例二倍体肿瘤和23例非整倍体肿瘤中的19例(83%)表现出肿瘤内DNA稳定性。4例(17%)非整倍体肿瘤显示出区域DNA异质性,表现为至少一个样本中存在额外的干系。21例FNA取材充足,7例取材不足,无法进行完整分析。总体而言,FNA与组织分析之间具有良好的相关性。然而,在3例非整倍体肿瘤中,FNA材料未显示出组织标本中所观察到的额外非主导干系。作者将这一发现归因于抽吸材料中的稀释因素。作者得出结论,大多数非小细胞肺癌表现出DNA稳定性;在大多数情况下,FNA可为FCM提供足够的细胞材料。

相似文献

1
Intratumoral DNA content variability. A study of non-small cell lung cancer.肿瘤内DNA含量变异性。一项关于非小细胞肺癌的研究。
Am J Clin Pathol. 1991 Sep;96(3):311-7. doi: 10.1093/ajcp/96.3.311.
2
[Relationship between cellular DNA contents and cell proliferation of non-small cell lung cancer estimated by simultaneous quantification of PCNA and DNA contents by flow cytometer].
Gan To Kagaku Ryoho. 1995 Jun;22 Suppl 2:164-7.
3
In situ evaluation of growth fraction determined by monoclonal antibody Ki-67 and ploidy in surgically resected non-small cell lung cancers.通过单克隆抗体Ki-67和倍性对手术切除的非小细胞肺癌生长分数进行原位评估。
Cancer Res. 1990 Jul 15;50(14):4382-7.
4
[Proliferative activity assessed on the basis of DNA ploidy patterns in primary lung cancer].[基于原发性肺癌DNA倍体模式评估增殖活性]
Nihon Geka Gakkai Zasshi. 1991 May;92(5):598-602.
5
[Intratumoral heterogeneity of DNA content in lung adenocarcinoma].[肺腺癌中DNA含量的肿瘤内异质性]
Jpn J Thorac Cardiovasc Surg. 1998 Aug;46(8):712-8. doi: 10.1007/BF03217807.
6
Flow cytometric DNA analysis of renal-cell carcinoma. A study of fine needle aspiration biopsies in comparison with multiple surgical samples.肾细胞癌的流式细胞术DNA分析。针吸活检与多个手术样本的比较研究。
Anal Quant Cytol Histol. 1987 Dec;9(6):505-8.
7
DNA stemline heterogeneity of non-small cell lung carcinomas and differences in DNA ploidy between carcinomas and metastatic nodes.非小细胞肺癌的DNA干系异质性以及癌组织与转移淋巴结之间的DNA倍体差异。
Lung Cancer. 1994 Sep;11(3-4):201-8. doi: 10.1016/0169-5002(94)90540-1.
8
Accuracy of the bronchoscopic DNA content analysis of non-small-cell lung carcinoma.非小细胞肺癌支气管镜下DNA含量分析的准确性
J Surg Oncol. 1992 Mar;49(3):182-8. doi: 10.1002/jso.2930490311.
9
Prognostic and therapeutic significance of the flow cytometric nuclear DNA content in non-small cell lung cancer.非小细胞肺癌中流式细胞术检测核DNA含量的预后及治疗意义
Cancer. 1990 Mar 15;65(6):1391-5. doi: 10.1002/1097-0142(19900315)65:6<1391::aid-cncr2820650624>3.0.co;2-k.
10
Comparative DNA analysis by image cytometry and flow cytometry in non-small cell lung cancer.非小细胞肺癌中图像细胞术和流式细胞术的比较性DNA分析
Jpn J Cancer Res. 1994 Nov;85(11):1171-7. doi: 10.1111/j.1349-7006.1994.tb02924.x.

引用本文的文献

1
Aneuploidy and prognosis of non-small-cell lung cancer: a meta-analysis of published data.非小细胞肺癌的非整倍体与预后:已发表数据的荟萃分析
Br J Cancer. 2001 Jul 6;85(1):14-22. doi: 10.1054/bjoc.2001.1892.
2
[Intratumoral heterogeneity of DNA content in lung adenocarcinoma].[肺腺癌中DNA含量的肿瘤内异质性]
Jpn J Thorac Cardiovasc Surg. 1998 Aug;46(8):712-8. doi: 10.1007/BF03217807.